Mass balance and metabolite profiles in humans of tegoprazan, a novel potassium-competitive acid blocker, using ¹⁴C-radiolabelled techniques.

求助中 10 由 Franco 发布于 2026/10/14 13:49:56

DOI:10.1080/17425255.2025.2505637
作者：Yicong Bian,?Jinjie Yuan,?Sheng Ma,?Jiang Nan,?Zheming Gu,?Hao Feng,?Zhenwen Yu,?Zhenteng Liu,?Fang Xie,?Yinghui Wang,?Chengxin Liu,?Hua Zhang,?Liyan Miao
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Background: Tegoprazan (LXI-15028), a novel potassium-competitive acid blocker, has shown great efficacy in treating acid-related disorders. However, its metabolic and excretion characterist

应助信息

等您来应助

上传文件

17小时前

Book学术机器人

2026/10/14 13:49:56 未找到该文献，机器人已退出，请等待人工下载

2026/10/14 13:49:56 Book学术AI机器人收到请求，开始寻找文献

2026/10/14 13:49:56 已向机器人发送请求

17小时前

Franco 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierImpulsive components separation using minimum-determinant KL-divergence NMF of bi-variable map for bearing diagnosis

Mass balance and metabolite profiles in humans of tegoprazan, a novel potassium-competitive acid blocker, using 14C-radiolabelled techniques.

Mass balance and metabolite profiles in humans of tegoprazan, a novel potassium-competitive acid blocker, using ¹⁴C-radiolabelled techniques.